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Abstract In recent years, there has been rising interest in
Streptococcus group Milleri (SM) because high mortality
rates have been related to it. In case of deep neck infections
(DNI), whatever the origin, mortality rates as high as 26 %
were reported. But there are no data available for DNI with
SM of purely dental origin. The aim of our article was to
describe and analyse DNI of purely dental origin involving
on one hand SM and on the other hand infections without
presence of SM. We compared these two groups and sta-
tistically investigated if there were differences in clinical
presentation (age, mouth opening, length of hospital stay,
laboratory parameters) or clinical behaviour (re-operation,
re-hospitalisation, secondary osteomyelitis, stay at inten-
sive care, length of antibiotic treatment, presence of
resistances against antibiotics, incapacity to work). For
this, we retrospectively searched medical records of our
institution for all purulent DNI treated from 2004 till 2012.
We found 81 patients meeting all inclusion criteria. Thirty-
four patients had involvement of SM, 47 did not. The only
statistically significant difference between the SM group
and the non-SM group was the length of incapacity to
work. All other parameters were non-significant. Further-
more, there were no fatalities. In conclusion, the clinical
importance of this article is that patients with deep neck
abscesses of purely dental origin involving SM do not need
more or different care when compared to all other DNI of
dental origin.
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Introduction
In 1956, GUTHOF, a German microbiologist, discovered a
new species of bacteria within the Streptococcus viridians
organisms and he named it Streptococcus Milleri. This was
to honour Willoughby D. Miller (1853–1907), an American
dentist and the first oral microbiologist [1]. At present, the
term Streptococcus group Milleri (SM) refers to a triad of
bacteria consisting of Streptococcus anginosus, Strepto-
coccus constellatus and Streptococcus intermedius [2–4].
These bacteria belong to the normal flora of human mucosa
[2] and can be found all over the body. Streptococcus
anginosus is more commonly encountered in the gastro-
intestinal and urinary tract, S. constellatus in the gastro-
intestinal or respiratory tract, while S. intermedius is
mostly found in the head and neck [5]. Even though
commensals, SM are associated with pyogenic infections
[2–4, 6] and are said to lead to suppurative complications at
a high rate [7].
In recent years, there has been rising interest in SM
[3, 4, 6, 8]. High mortality rates have been related to
infections with SM, for instance for generalised bacter-
aemia with a mortality rate of 4 % [3]. In case of deep
neck infections, whatever the origin, mortality rates as
high as 26 % were reported [9], but there are no data
available concerning infections with SM of purely dental
origin. The aim of our article is to describe and analyse
deep neck space abscesses (DNA) of dental origin for
infections involving, on one hand, SM and, on the other,
infections without the presence of SM and to compare
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these two groups. Statistical tests were performed to find
differences in clinical presentation and behaviour.
Materials and methods
We retrospectively searched the medical records from 2004
until the end of 2012 of our department. We included
patients meeting the following criteria:
– DNA with the presence of pus. Only abscesses located
in the following spaces were included: masticator,
buccal, sublingual, submandibular, parapharyngeal,
carotid sheath, retropharyngeal, prevertebral and vis-
ceral space. These neck spaces are defined in more
detail by Mukherji et al. [10]. Minor local dental
abscesses within the vestibulum oris were excluded.
– The infection was of dental origin and the related tooth
was identified.
– Surgical treatment with incision and drainage, extraoral
and/or intraoral.
– The presence of bacteriological cultures for all patients.
By means of statistical software (PASW Statistics,
version 18.0.0), we performed descriptive statistics for
age, sex, the length of hospital stay, length of antibiotic
treatment including hospital stay and post-hospitalisation
time, presence of antibiotic resistances, the initial
inflammatory parameters (full white blood cell count,
C-reactive protein, temperature measured in the ear-
drum), the initial mouth opening, complications (re-hos-
pitalisation, re-operations, osteomyelitis, need for
intensive care) and the total number of days with inca-
pacity to work including hospital stay. Then all patients
were stratified into an SM group and a non-SM group
and the descriptive statistics were repeated. With a
Mann–Whitney U test, we analysed differences of results
for the SM and non-SM group. A p B 0.05 was judged
significant. We investigated antibiotic resistance and
complications as an influencing factor with a Fisher
exact test; a p B 0.05 was judged as significant. We also
identified the antibiotics used during the hospital stay for
the entire group and made an overview of the bacteria
involved other than SM. Mortality was examined.
Results
The results for the entire patient group are summarised
in Table 1. 42 % of all patients had an involvement of
SM, while SM was absent in 58 %. Tables 2 and 3 show
the results stratified for the SM and non-SM groups. The
only statistically significant difference between the SM
group and the non-SM group is the length of incapacity
to work. All other parameters are deemed non-signifi-
cant. The antibiotics administered are summarised in
Table 4. Apart from SM, 28 different germs were found.
The three most frequent were: Streptococcus alpha-hae-
molyticus (109), Staphylococcus epidermidis (99), and
Parvimonas micra (69). Of the 28 germs, 16 were found
only once. More details are displayed in Table 5. No
patient succumbed due to the DNA with or without SM
in the present study.
Discussion
The results show that there was no statistical difference in
the clinical presentation (age, mouth opening, length of
hospital stay), the laboratory parameters (C-reactive pro-
tein, full blood cell count, temperature) or the length of
antibiotic treatment between patients with DNA of dental
origin with or without the presence of SM. SM and non-SM
patients are statistically not different regarding their
potential for complications (re-operation, re-hospitalisa-
tion, secondary osteomyelitis), and the presence of resis-
tances against antibiotics in the SM and non-SM group did
not significantly alter the outcome. The only statistically
significant difference between the SM group and the non-
SM group is the length of incapacity to work. We do not
have an explanation for this.
The present study also showed that the degree of
severity of disease in DNA of dental origin is probably
milder compared to other patient groups of other speci-
alities or anatomical sites. In head and neck DNA (all
aetiologies and germs confound), the available figures for
mortality rates are scattered and include 0 % [11], 0.3 %
[12], 0.65 % [13], 0.8 % [14], 1.6 % [15] and 2.4 %
[9].There is also one study investigating DNA with SM
with a 14 % mortality rate, but it is based on only seven
patients and therefore not completely reliable [4]. In our
group with purely dental infections, no patient died due
Table 1 Overview of standard variables for all patients
Number of
patients
Mean Standard
deviation
Age in years 81 41.9 18.7
Length of hospital stay in days 81 6.3 6.6
Length of antibiotic treatment in
days
67 14.7 11.2
White blood cell count in g/l 76 14.4 4.8
C-reactive protein in mg/l 61 151.8 125.8
Temperature in C 58 37.4 0.7
Mouth opening in mm measured
between the incisors
60 16.7 7.8
Incapacity to work in days 40 17.1 7.7
2772 Eur Arch Otorhinolaryngol (2014) 271:2771–2774
123
to DNA. This backs previous observations that in the
head and neck, patients with DNA of purely dental
origin heal better than DNA caused by any other aeti-
ology [16, 17]. In the present study this may also be
influenced by the high availability of medical care and
mandatory health insurance for the entire population in
our country.
Although SM has gained interest in the last few years,
publications for head and neck are rare and the number of
published patients is rather low. The number of patients
included in up-to-date available reports is 6 [9], 7 [4], 12
[18] and 17 [6] in adult cohorts and 16 in a paediatric
cohort [8]. But in all these reports, the aetiologies and
germs are heterogeneous. In contrast to this, in the present
study the patient group is homogeneous. It includes only
infections of purely dental origin: 34 of them with SM and
47 without. Given the absence of similar studies, an exact
comparison with other published data was not possible.
In conclusion, the clinical importance of this article is
that maxillofacial patients with DNA of purely dental ori-
gin involving SM do not need more or different care when
compared with all other DNA of dental origin.
Table 2 Numeric standard variables for SM and non-SM patients
Number of
patients
Mean Standard
deviation
p
Age in years
SM 34 45.12 16.5 0.143
Non-SM 47 39.5 19.9
Length of hospital stay in days
SM 34 7.7 7.7 0.151
Non-SM 47 5.3 5.6
Length of antibiotic treatment in days
SM 28 16.2 13.8 0.429
Non-SM 39 13.6 9.0
White blood cell count in g/l
SM 30 14.3 4.6 0.979
Non-SM 46 14.4 5.0
C-reactive protein in mg/l
SM 22 177.9 126.4 0.117
Non-SM 39 137.0 124.7
Temperature in C
SM 23 37.4 0.8 0.577
Non-SM 35 37.5 0.7
Mouth opening in mm measured between the incisors
SM 27 17.7 13.7
Non-SM 33 15.8 9.0
Incapacity to work in days
SM 18 20.5 7.8 0.010*
Non-SM 22 14.3 6.5
A Mann–Whitney U test was performed to investigate statistically
significant differences
* The significance level was p B 0.05
Table 3 Categorical variables for SM and non-SM patients in
n = patients and % where appropriate
For all 81
patients (in %)
SM patients
(in %)
Non-SM
patients (in %)
p
Sex
Female 26 (32.1) 11 (13.6) 15 (18.5) –
Male 55 (67.9) 23 (28.4) 32 (39.5)
Re-hospitalisations
Yes 6 (7.4) 3 (3.7) 3 (3.7) –
No 75 (92.6)
Stay at intensive care
Yes 6 (7.4) 3 (3.7) 3 (3.7) –
No 75 (92.6)
Secondary osteomyelitis
Yes 3 (3.7) 1 (1.2) 2 (2.5) –
No 78 (96.3)
Antibiotic resistances for the causing bacteria
Yes 28 (34.5) 17 (21.0) 11 (13.6) 0.21
No 20 (24.7) 16 (19.8) 4 (4.9)
Not tested 33 (40.8) 1 (1.2) 32 (39.5)
Complications (re-operations, osteomyelitis, intensive care)
Yes 16 (19.8) 7 (8.6) 9 (11.1) 1.0
No 65 (80.2) 27 (33.3) 38 (46.9)
A Fisher exact test was performed to investigate statistically signifi-
cant differences for the last two variables
Table 4 Antibiotics used in this study
Dose Mode Number
of
patients
Percent
Amoxicillin/
clavulanic acid
3 9 1,000/
200 mg
i.v.a 61 75
Clindamycin 3 9 600 mg i.v. 12 12
Imipenem/cilastin 4 9 500/
4 9 500 mg
i.v. 3 4
Amoxicillin 3 9 1,000 mg i.v. 3 4
Amoxicillin/
clavulanic acid and
metronidazole
3 9 1,000/200
and
2 9 500 mg
i.v. 2 2
Clindamycin and
metronidazole
3 9 600 and
2 9 500 mg
i.v. 1 1
The 12 patients who received clindamycin were all allergic to
penicillin
a All antibiotics were given intravenously except for one patient
(amoxicillin/clavulanic acid, 3 9 500/125 mg)
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Table 5 Bacteria other than SM found in this study
Bacteria Found in testing
Streptococcus alpha-haemolyticus 10
Staphylococcus epidermidis 9
Parvimonas micra 6
Candida albicans 5
Streptococcus mitis 4
Fusobacterium sp. 4
Slackia exigua 3
Staphylococcus coagulase-negative 3
Streptococcus massiliensis 2
Escherichia coli 2
Haemophilus influenzae 2
Enterococcus faecalis 2
Staphylococcus capitis 1
Candida glabrata 1
Streptococcus peroris 1
Prevotella buccae 1
Eikenella corrodens 1
Neisseria sp. 1
Pseudomonas aeruginosa 1
Streptococcus sanguinis 1
Streptococcus beta-hemolyticus group C 1
Corynnebacterium 1
Streptococcus parasanguinis 1
Lactobacillus gasseri 1
Bacteroides heparinolyticus 1
Prevotella intermedia 1
Veilonella parvula 1
Propionibacterium acnes 1
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